BRAF and TERT promoter mutations: clinical application in thyroid cancer

JH Chung - Endocrine Journal, 2020 - jstage.jst.go.jp
Given the long-term survival of most patients with thyroid cancer, it is very important to
distinguish patients who need aggressive treatment from those who do not. Conventional …

[HTML][HTML] Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular …

U Cho, O Mete, MH Kim, JS Bae, CK Jung - Modern Pathology, 2017 - Elsevier
Thyroid tumors formerly classified as non-invasive encapsulated follicular variant of papillary
thyroid carcinoma were recently renamed 'non-invasive follicular thyroid neoplasm with …

[HTML][HTML] Non-coding RNAs: uncharted mediators of thyroid cancer pathogenesis

H Tabatabaeian, S Peiling Yang, Y Tay - Cancers, 2020 - mdpi.com
Simple Summary Thyroid cancer is the most common type of endocrine system malignancy.
The effective diagnosis, precise treatment, and better short and long-term prognosis of …

Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal …

CA Routhier, MC Mochel, K Lynch, D Dias-Santagata… - Human pathology, 2013 - Elsevier
BRAF mutation is seen in a variety of human neoplasms including cutaneous malignant
melanoma, papillary thyroid carcinoma, colorectal carcinoma, non–small cell lung …

[HTML][HTML] Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

JS Bae, Y Kim, S Jeon, SH Kim, TJ Kim, S Lee… - Diagnostic …, 2016 - Springer
Background Mutations in the TERT promoter, ALK rearrangement, and the BRAF V600E
mutation are associated with aggressive clinicopathologic features in thyroid cancers …

[PDF][PDF] The frequency and clinical implications of the BRAFV600E mutation in papillary thyroid cancer patients in Korea over the past two decades

AR Hong, JA Lim, TH Kim, HS Choi… - Endocrinology and …, 2014 - synapse.koreamed.org
Background: Over the past several decades, there has been a rapid worldwide increase in
the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the …

Genetic alterations of differentiated thyroid carcinoma in iodine‐rich and iodine‐deficient countries

HG Vuong, T Kondo, N Oishi, T Nakazawa… - Cancer …, 2016 - Wiley Online Library
Abstract BRAF V600E mutation, RET rearrangements, and RAS mutations are the common
genetic alterations in differentiated thyroid carcinomas derived from follicular thyroid cells …

A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on …

A Kuchareczko, J Kopczyński, A Kowalik… - Thyroid, 2022 - liebertpub.com
Background: The incidence of papillary thyroid cancer is increasing worldwide due to more
frequent pathological detection of papillary thyroid microcarcinomas (PTMC), which are …

Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?

P Soares, R Celestino… - … Journal of Surgical …, 2014 - journals.sagepub.com
The incidence of papillary thyroid microcarcinoma (PTmC) has been increasing everywhere
due to the improvement of imaging and morphological diagnoses and probably also due to …

Molecular Genotyping of Follicular Variant of Papillary Thyroid Carcinoma Correlates with Diagnostic Category of Fine-Needle Aspiration Cytology: Values of RAS …

SR Lee, CK Jung, TE Kim, JS Bae, SL Jung, YJ Choi… - Thyroid, 2013 - liebertpub.com
Background: The follicular variant of papillary thyroid carcinoma (FVPTC) presents distinct
histologic subtypes and molecular genotyping. The preoperative diagnosis of FVPTC …